Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
16,450
Total Claims
$1.4M
Drug Cost
1,129
Beneficiaries
$1,266
Cost/Patient
Risk Score Breakdown 15/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
+194%
Opioid rate vs peers
7.6% vs 2.6% avg
+19%
Cost per patient vs peers
$1,266 vs $1,068 avg
+25%
Brand preference vs peers
11.3% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
7.6%
Opioid Rate
1,247
Opioid Claims
$49K
Opioid Cost
6.9%
Long-Acting Rate
Brand vs Generic
Brand: 1,840 claims · $1.1M
Generic: 14,468 claims · $305K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Tasimelteon | 11 | $290K |
| Apixaban | 211 | $173K |
| Empagliflozin | 120 | $138K |
| Semaglutide | 46 | $50K |
| Budesonide/Formoterol Fumarate | 75 | $37K |
| Rivaroxaban | 53 | $36K |
| Tirzepatide | 30 | $33K |
| Dapagliflozin Propanediol | 21 | $28K |
| Sitagliptin Phosphate | 14 | $25K |
| Fluticasone/Umeclidin/Vilanter | 24 | $25K |
| Hydrocodone/Acetaminophen | 688 | $24K |
| Dulaglutide | 18 | $22K |
| Fluticasone Propion/Salmeterol | 36 | $18K |
| Insulin Glargine,hum.Rec.Anlog | 24 | $18K |
| Umeclidinium Brm/Vilanterol Tr | 34 | $17K |
Prescribing Profile
Patient Profile
73
Avg Age
51%
Female
1.26
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About